Dr Frank Prendergast has a long and distinguished career in the US Healthcare industry with some of his more notable achievements as director for research at Mayo Clinic, member of the Board of Governors for Mayo Clinic and member of Mayo Clinic’s Executive Committee. Dr Prendergast has been a member of the Eli Lilly Company board of directors since 1995, and has served extensively in US National Institutes of Health in various capacities. Dr Prendergast has been non-executive director of Medibio and his vision is to use his extensive network in the US healthcare industry to expand Medibio’s advisory board, and as a platform to assist in the commercialisation of Medibio’s technology for the diagnosis of depression and other mental health disorders.
